More recently, we also found in hAPP-J20 AD transgenic mice that treatment with NitroSynapsin produced S-nitrosylation of GluN1 subunits of the NMDA receptor and protected dendritic networks as well as presynaptic structures (Ghatak et al., 2021a). Here, GRIN1 is linked to Alzheimer disease.